Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-753-8 | CAS number: 53770-52-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 May 2011 to 23 May 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD guideline and GLP compliant study.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Zinc 3,5-bis(α-methylbenzyl)salicylate
- EC Number:
- 258-753-8
- EC Name:
- Zinc 3,5-bis(α-methylbenzyl)salicylate
- Cas Number:
- 53770-52-8
- Molecular formula:
- C46H42O6Zn
- IUPAC Name:
- zinc 3,5-bis(α-methylbenzyl)salicylate
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- - Name of test material (as cited in study report): zinc 3,5-bis(α-methylbenzyl)salicylate
- Molecular formula (if other than submission substance): C46H42O6Zn
- Molecular weight (if other than submission substance): 756.21
- Physical state: White powder
- Analytical purity: 99.0%
- Lot/batch No.: 31205
- Expiration date of the lot/batch: December 2013
- Storage condition of test material: Room temperature (15-25°C)
- Other:
- Manufacture date: December 2003
- Safety precautions: Routine safety precautions (lab coat, gloves, goggles, face mask) for unknown materials will be applied to assure personnel health and safety
Constituent 1
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: S&K-LAP Kft., 2173 Kartal, Császár út 135, Hungary
- Age at study initiation: ~16 weeks old (adult)
- Weight at beginning of life phase: 3834 - 4036 g
Weight at end of life phase: 3513 - 4299 g
- Housing: Rabbits were individually housed in AAALAC approved metal wire rabbit cages. Cages were of an open wire structure and cages were placed together to allow some social interaction with rabbit(s) in adjoining cages
- Diet (e.g. ad libitum): Animal received PURINA Base - Lap gr. diet for rabbits produced by AGRIBRANDS Europe Hungary PLC, H-5300 Karcag, Madarasi road, Hungary, ad libitum.
- Water (e.g. ad libitum): The animals received municipal tap water, as for human consumption, ad libitum, from an automatic system.
- Acclimation period: 40 days
- Date of receipt of rabbits: 23 March 2011
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20±3
- Humidity (%): 24-67
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): Light 12 hours daily, from 6.00am to 6.00pm
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: Untreated right eye
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): A single dose of 0.1 g of the solid test item zinc 3,5-bis(α-methylbenzyl)salicylate was administered to each animal - Duration of treatment / exposure:
- The treated eye of the rabbits was rinsed at 1 hour after application with physiological saline solution.
- Observation period (in vivo):
- 3 weeks
- Number of animals or in vitro replicates:
- 3 males
- Details on study design:
- REMOVAL OF TEST SUBSTANCE
- Washing (if done): The treated eye of the rabbits was rinsed with physiological saline solution.
- Time after start of exposure: 1 hour
SCORING SYSTEM:
- Scoring and Assessment of Local Reaction: The eye irritation scores were evaluated according to the scoring system by Draize (1977) and OECD 405 (24 April 2002) shown in Appendix 1 of attached report.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- mean
- Time point:
- other: 24, 48, 72 hours
- Score:
- 1.9
- Max. score:
- 4
- Reversibility:
- fully reversible within: 3 weeks
- Irritation parameter:
- iris score
- Basis:
- mean
- Time point:
- other: 24, 48, 72 hours
- Score:
- 0
- Max. score:
- 2
- Irritation parameter:
- conjunctivae score
- Basis:
- mean
- Time point:
- other: 24, 48, 72 hours
- Score:
- 2.8
- Max. score:
- 3
- Reversibility:
- not fully reversible within: 3 weeks
- Irritation parameter:
- chemosis score
- Basis:
- mean
- Time point:
- other: 24, 48, 72 hours
- Score:
- 2.9
- Max. score:
- 4
- Reversibility:
- fully reversible within: 2 weeks
- Irritant / corrosive response data:
- -Examination of eye-irritancy:
Initial Pain Reaction (IPR) (score 1 or 2) was observed in all animals.
One hour after the application, conjunctival redness (score 1 or 2) was observed in all animals, discharge (score 1 or 3) and chemosis (score 1 or 3) were seen in all rabbits. All animals showed corneal opacity (score 1, areas 2, 3 and 4).
At 24 hours after treatment conjunctival redness (score 3) was observed in all animals, discharge (score 3) and chemosis (score 2, 3 or 4) were seen in all rabbits. All animals showed corneal opacity (score 1, areas 2, 3 and 4).
At 48 hours after treatment, conjunctival redness (score 2 or 3) was observed in all animals, discharge (score 3) and chemosis (score 1 or 4) were seen in all rabbits. All animals showed corneal opacity (score 2 or 3, areas 2 and 3).
At 72 hours after treatment, conjunctival redness (score 2 or 3) was observed in all animals, discharge (score 2 or 3) and chemosis (score 1, 3 or 4) were seen in all rabbits. All animals showed corneal opacity (score 2 or 3, area 2 or 3).
At one week after treatment, conjunctival redness (score 1 or 2) was observed in all animals, discharge (score1 or 3) and chemosis (score 1) were seen in two rabbits. One animal showed corneal opacity (score 2, area 4) and iris was reactive in one animal (score 1).
At two weeks after treatment, conjunctival redness (score 1) was observed in all animals and discharge (score 1) was seen in two rabbits. One animal showed corneal opacity (score 1, area 1).
At three weeks after treatment, conjunctival redness (score 1) was observed in two animals and discharge (score 1) was seen in two rabbits. During the study, the control eye of all animals was symptom-free. The general state and behaviour of animals were normal throughout the study period. There were no notable body weight changes during the study period.
The animal’s individual mean scores (considering readings at 24, 48 and 72 hours after the treatment) were as follows:
chemosis : 4.00, 3.00, 1.67
discharge : 3.00, 3.00, 2.67
redness : 3.00, 3.00, 2.33
cornea opacity : 2.33, 1.67, 1.67
iris: 0.00, 0.00, 0.00
Any other information on results incl. tables
-Mortality: There was no mortality observed during the study.
-Body weights: The mean body weight and the mean body weight change were considered to be normal with no indication of treatment related effect.
Clinical Observation:
-General daily examination: There were no clinical signs observed that could be related to treatment.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test item zinc 3,5-bis(α-methylbenzyl)salicylate (Batch No.: 31205), applied to rabbits’ eye mucosa, caused significant conjunctival and corneal irritant effects at one hour which were not reduced at 24 hours after application. The effects were not fully reversible within 3 weeks.
According to Regulation (EC) No 1272/2008, zinc 3,5-bis(α-methylbenzyl)salicylate requires classification as an eye irritant (Irreversible effects on the eye/serious damage to eyes (Category 1)). - Executive summary:
An acute eye irritation study of the test item zinc 3,5-bis(α-methylbenzyl)salicylate was performed in New Zealand White rabbits. The irritation effects of the test item were evaluated according to the Draize method (OECD No.: 405, 2002).
The test item was placed into the conjunctival sac of the left eye of each animal. The untreated right eye served as control. An amount of 0.1 g of the test item was administered as a single dose. The treated eye of the rabbits was rinsed at 1 hour after application with physiological saline solution.
The eyes were examined at 1, 24, 48, 72 hours and 1, 2 and 3 weeks after the application.
Initial Pain Reaction (IPR) (score 1 or 2) was observed in all animals.
One hour after the application, conjunctival redness (score 1 or 2) was observed in all animals, discharge (score 1 or 3) and chemosis (score 1 or 3) were seen in all rabbits. All animals showed corneal opacity (score 1, areas 2, 3 and 4).
At 24 hours after treatment conjunctival redness (score 3) was observed in all animals, discharge (score 3) and chemosis (score 2, 3 or 4) were seen in all rabbits. All animals showed corneal opacity (score 1, areas 2, 3 and 4).
At 48 hours after treatment, conjunctival redness (score 2 or 3) was observed in all animals, discharge (score 3) and chemosis (score 1or 4) were seen in all rabbits. All animals showed corneal opacity (score 2 or 3, areas 2 and 3).
At 72 hours after treatment, conjunctival redness (score 2 or 3) was observed in all animals, discharge (score 2 or 3) and chemosis (score 1, 3 or 4) were seen in all rabbits. All animals showed corneal opacity (score 2 or 3, area 2 or 3).
At one week after treatment, conjunctival redness (score 1 or 2) was observed in all animals, discharge (score1 or 3) and chemosis (score 1) were seen in two rabbits. One animal showed corneal opacity (score 2, area 4) and iris was reactive in one animal (score 1).
At two weeks after treatment, conjunctival redness (score 1) was observed in all animals and discharge (score 1) was seen in two rabbits. One animal showed corneal opacity (score 1, area 1).
At three weeks after treatment, conjunctival redness (score 1) was observed in two animals and discharge (score 1) was seen in two rabbits.
During the study, the control eye of all animals was symptom-free.
The general state and behaviour of animals were normal throughout the study period.
There were no notable body weight changes during the study period.
The animal’s individual mean scores (considering readings at 24, 48 and 72 hours after the treatment) were as follows:
chemosis : 4.00, 3.00, 1.67
discharge : 3.00, 3.00, 2.67
redness : 3.00, 3.00, 2.33
cornea opacity : 2.33, 1.67, 1.67
iris : 0.00, 0.00, 0.00
According to Regulation (EC) No 1272/2008, zinc 3,5-bis(α-methylbenzyl)salicylate requires classification as an eye irritant (Irreversible effects on the eye/serious damage to eyes (Category 1)).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
